// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Liquid crystalline ordering of antimicrobial peptide-RNA complexes controls TLR3 activation

E.Y. Lee - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriasis

N/A

Analysis of the paired TCR alpha- and beta-chains of single, intralesional CD8+T-cells in alopecia areata patients

M. Bertolini - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Minoxidil

An investigation of Lamin A autoantibodies in vitiligo

S. Faraj - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Vitiligo

Prezatide copper acetate

Basal cell carcinoma cancer stem cells promote immune evasion

S. Lanfredini - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Basal cell carcinoma

Interferon Gamma

Mutational landscape of highly malignant recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma

R. Cho - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Cutaneous squamous cell carcinoma

TP53

Targeting TGFβ signaling in BRAF mutant melanoma

L. Spender - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Melanoma

Vemurafenib

Systematic review of atopic dermatitis disease definitions in routinely-collected health data

M.P. Dizon - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

N/A

Does atopic dermatitis remain a disease of the advantaged in adulthood? A national birth cohort study

K. Abuabara - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

N/A

The prevalence of eczema beyond childhood: A systematic review and meta-analysis of longitudinal studies

A.M. Yu - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

N/A

Brentuximab vedotin demonstrates superior activity to standard therapy in CD30-expressing (CD30+) cutaneous T-cell lymphoma (CTCL) in the randomized phase 3 ALCANZA study

Y.H. Kim - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cutaneous T-cell lymphoma

Adcetris

Bone marrow/cord blood transplantation (BMCBT) ameliorates symptoms in some, but not all, subtypes of severe generalized junctional epidermolysis bullosa (JEB)

K. Hook - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Epidermolysis bullosa

N/A

Matching-adjusted indirect comparisons of Ixekizumab and Secukinumab using Etanercept and Ustekinumab Bridge Comparators

J. Wu - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriasis

secukinumab

Acne Core Outcomes Research Network (ACORN) reaches consensus on outcomes to measure

D. Thiboutot - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

N/A

Topical carbamide peroxide for treatment of mild to moderate acne vulgaris

J.E. Bernstein - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Acne

carbamide peroxide

Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB)

J. Tolar - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Epidermolysis bullosa

N/A

Redefining colour and redness in cutaneous healing and scarring: Quantitative evaluation of erythema and pigmentation in human skin corroborated by immunohistochemical analysis

S. Ud-Din - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Vps33b-Vipar complex is required for epidermal homeostasis

C. Rogerson - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Renal insufficiency

N/A

Optimised detection of mitochondrial DNA strand breaks in human skin

R.L. Hanna - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of hypoxia in control of CK1 expression and keratinocyte differentiation in monolayer culture and 3D skin equivalents

L. Usakin - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Production of Serotonin and N-acetylserotonin in the human skin in vivo

A. Slominski - International Investigative Dermatology/Society for Investigative Dermatology (IID/SID) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

tryptophan

Copyright © 2026. QuantiNova All rights reserved